• Twenty patients with 21 primary colorectal adenocarcinomas were studied with 2 mCi (7.6 ×107 becquerels) of indium-labeled monoclonal antibody (200 μg) specific for carcinoembryonic antigen (CEA). Fifteen lesions (71%) were visualized by gamma camera scintigraphy at 48 hours postinjection. Tumors that were identified by immunoscintigraphy were large (38.10±17.76 cm3 vs 6.00±1.65 cm3), had a grossly fungating component, had a high content of CEA by enzyme immunoassay (12.9±3.6 μg/g vs 3.3±1.7 μg/g), and had an apical and/or intraluminal staining pattern on immunohistologic section. Patients whose tumors were visualized had a low serum CEA level (1.9±0.4 ng/mL vs 14.6± 8.0 ng/mL). Prospective selection of patients for follow-up imaging or therapy with radiolabeled monoclonal antibodies may be feasible using these measurements.
(Arch Surg 1986;121:1315-1319)
Duda RB, Beatty JD, Sheibani K, Williams LE, Paxton RJ, Beatty BG, Shively JE, Vlahos WG, Werner JL, Kemeny MM, Kokal WA, Riihimaki DU, Wagman LD, Terz JJ. Imaging of Human Colorectal Adenocarcinoma With Indium-Labeled Anticarcinoembryonic Antigen Monoclonal Antibody. Arch Surg. 1986;121(11):1315-1319. doi:10.1001/archsurg.1986.01400110107018